NEW ORLEANS -- Innovations in lipid lowering get a major chance to shine, and potentially move the needle in cardiometabolic ...

Researchers have developed a DNA-based therapy that targets the PCSK9 gene to lower cholesterol naturally. Using polypurine hairpins, they increased cholesterol uptake by cells and reduced ...

For decades, statins like Lipitor and Zocor have been the cornerstone of cholesterol management. But as experts note, they don’t work for everyone — and now, a new wave of advanced therapies is ...

A new gene therapy shows promise in controlling cholesterol by lowering bad LDL levels, potentially reducing the risk of ...

AUSTIN, Texas and TOKYO, Nov. 14, 2025 /PRNewswire/ -- According to DataM Intelligence, the Cardiovascular Biologics Market Size was valued at approximately USD 2.20 billion in 2024 and is projected ...

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.

A statin isn’t the only answer anymore to lowering cholesterol. The lipid-reducing medicines, among the most widely prescribed drugs in the U.S., have been a mainstay of heart-disease prevention and ...

PCSK9 inhibition may be a suitable alternative for statin-intolerant patients, and recent data demonstrated its efficacy as ...

A report on gene-editing drugs renews debate around long-term statin use as Indian cardiologists caution that risk assessment ...

In a phase 1 trial, a gene-editing therapy that targets ANGPTL3 was associated with few serious adverse events and at higher ...

For years, cell and gene therapies were mainly associated with rare and orphan diseases, those that impact small patient groups and lack effective treatment options. However, recent developments in ...